GO:0006120 mitochondrial electron transport, NADH to ubiquinone: Complex I Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006120 describes the transfer of electrons from NADH to ubiquinone during oxidative phosphorylation, a reaction catalyzed by mitochondrial complex I (NADH:ubiquinone oxidoreductase).
• Complex I is a large L-shaped membrane protein assembly that couples NADH oxidation and ubiquinone reduction to proton translocation across the inner mitochondrial membrane.
• The reaction is a central entry point for electrons into the respiratory chain and is essential for ATP production and cellular metabolism.
• Ubiquinol oxidation downstream of complex I is necessary for tumour growth, linking this GO term to cancer biology.
• Defects in complex I assembly, including RTN4IP1-dependent late stages, impair both complex I and coenzyme Q biosynthesis.
• Complex I is a validated drug target, and artificial electron acceptors and inhibitors are used to probe its mechanism and develop potential medicines.
Description
GO:0006120, mitochondrial electron transport, NADH to ubiquinone, is the biological process in which electrons are transferred from NADH to ubiquinone (coenzyme Q) during oxidative phosphorylation. This reaction is carried out by mitochondrial complex I, also known as NADH:ubiquinone oxidoreductase or NADH dehydrogenase, the first and largest enzyme of the mitochondrial respiratory chain. Because it couples NADH oxidation to proton pumping, complex I establishes a proton motive force that drives ATP synthesis and is therefore central to cellular energy metabolism. Researchers study GO:0006120 to understand mitochondrial bioenergetics, the assembly and regulation of respiratory chain complexes, and the molecular basis of mitochondrial disease. The process is also relevant to cancer, because ubiquinol oxidation downstream of complex I is required for tumour growth. In addition, complex I is a target for pharmacological modulation, and artificial electron acceptors and inhibitors are widely used to dissect its catalytic mechanism and to develop potential medicines. Understanding this GO term therefore connects fundamental enzymology to human health and therapeutic development.
mitochondrial electron transport, NADH to ubiquinone At A Glance
| GO ID | GO:0006120 |
|---|---|
| GO term | mitochondrial electron transport, NADH to ubiquinone |
| Ontology | biological_process |
| Synonym | complex I (NADH to ubiquinone); oxidative phosphorylation, NADH to ubiquinone |
| Major function | Transfer of electrons from NADH to ubiquinone during oxidative phosphorylation, catalyzed by mitochondrial complex I |
| Cellular location | Inner mitochondrial membrane, as part of the respiratory chain |
| Key enzyme | NADH:ubiquinone oxidoreductase (complex I) |
| Electron donor | NADH |
| Electron acceptor | Ubiquinone (coenzyme Q) |
| Associated process | Proton translocation and oxidative phosphorylation |
What Is GO:0006120?
In simple terms, GO:0006120 is the step in cellular respiration where electrons are taken from NADH and handed to ubiquinone. According to the QuickGO definition, it is the transfer of electrons from NADH to ubiquinone that occurs during oxidative phosphorylation. This process is catalyzed by mitochondrial complex I, which oxidizes NADH, reduces ubiquinone to ubiquinol, and uses the energy released to pump protons across the inner mitochondrial membrane. The term is synonymous with complex I (NADH to ubiquinone) and oxidative phosphorylation, NADH to ubiquinone.
Why Is mitochondrial electron transport, NADH to ubiquinone Important in Cell Biology?
GO:0006120 is important because it represents the first and rate-limiting electron entry step of the mitochondrial respiratory chain, and its activity determines the efficiency of oxidative phosphorylation and ATP production. Complex I dysfunction is associated with a wide range of mitochondrial disorders, and the enzyme is a major source of reactive oxygen species when electron transfer is impaired. The process is also relevant to cancer metabolism, since ubiquinol oxidation downstream of complex I is necessary for tumour growth. Moreover, complex I is a druggable target, and understanding its interaction with artificial electron acceptors and inhibitors supports the development of potential medicines. Finally, the assembly of complex I, including late stages that require RTN4IP1 and intersect with coenzyme Q biosynthesis, is essential for the integrity of this process.
• Provides the main entry point for electrons from NADH into the respiratory chain.
• Couples electron transfer to proton translocation, generating the proton motive force for ATP synthesis.
• Dysfunction of complex I is linked to mitochondrial diseases and metabolic disorders.
• Ubiquinol oxidation downstream of complex I is necessary for tumour growth, connecting the process to cancer.
• Complex I is a target for inhibitors and potential medicines, making it pharmacologically important.
• Assembly of complex I, including RTN4IP1-dependent late stages, is required for the process and for coenzyme Q biosynthesis.
• The process is a source of reactive oxygen species when electron transfer is compromised.
• Artificial electron acceptors are used experimentally to probe the mechanism of NADH to ubiquinone electron transfer.
What Happens During mitochondrial electron transport, NADH to ubiquinone?
NADH binding and oxidation at complex I
In simple terms: NADH docks onto complex I and gives up its electrons.
The process begins when NADH binds to the hydrophilic arm of mitochondrial complex I and transfers two electrons to the enzyme's flavin mononucleotide (FMN) cofactor, oxidizing NADH to NAD+. This step is the entry point for reducing equivalents into the respiratory chain and is catalyzed by the NADH:ubiquinone oxidoreductase activity of complex I. The electrons are then passed along a chain of iron-sulfur clusters within the enzyme.
Electron transfer through iron-sulfur clusters
In simple terms: Electrons travel through a wire of iron-sulfur clusters inside complex I.
After NADH oxidation, electrons are transferred through a series of iron-sulfur clusters that span the hydrophilic and membrane arms of complex I, ultimately reaching the ubiquinone binding site. This intramolecular electron transport is essential for coupling the redox reaction to proton translocation. The efficiency of electron flux through the ubiquinone pool has been studied extensively, and the ubiquinone pool acts as a mobile electron carrier.
Ubiquinone reduction to ubiquinol
In simple terms: The electrons are handed to ubiquinone, converting it into ubiquinol.
At the quinone binding site, ubiquinone accepts two electrons and two protons to become ubiquinol, completing the NADH to ubiquinone electron transfer defined by GO:0006120. Ubiquinol then diffuses within the inner mitochondrial membrane to donate electrons to complex III, linking this process to downstream oxidative phosphorylation. The oxidation of ubiquinol is necessary for tumour growth, highlighting the biological importance of this step.
Proton translocation and energy coupling
In simple terms: The energy released by electron transfer is used to pump protons across the membrane.
The redox energy from NADH oxidation and ubiquinone reduction drives the translocation of protons from the mitochondrial matrix to the intermembrane space, contributing to the proton motive force. This proton pumping is a hallmark of complex I and couples GO:0006120 to ATP synthesis. Inhibitors and artificial electron acceptors have been used to dissect the coupling mechanism and to evaluate potential medicines targeting this process.
Assembly and maintenance of the electron transfer machinery
In simple terms: Complex I must be built correctly for electron transfer to work.
The NADH to ubiquinone electron transfer depends on the proper assembly of complex I, which involves multiple assembly factors and late stages that require RTN4IP1. RTN4IP1 is required for the final stages of mitochondrial complex I assembly and also for coenzyme Q biosynthesis, linking assembly to the availability of the ubiquinone substrate. Defects in assembly can impair the entire process and are associated with mitochondrial disease.
Key Genes Involved in GO:0006120 mitochondrial electron transport, NADH to ubiquinone
The following genes and proteins are central to mitochondrial electron transport, NADH to ubiquinone, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NDUFS1 | Core subunit of complex I hydrophilic arm | Mutations linked to complex I deficiency; target for functional studies |
| NDUFS2 | Core subunit of complex I | Essential for electron transfer and assembly |
| NDUFS3 | Core subunit of complex I | Involved in NADH oxidation and ubiquinone reduction |
| NDUFV1 | Flavoprotein subunit binding FMN | Catalytic NADH oxidation; disease mutations reported |
| NDUFV2 | Flavoprotein subunit | Electron entry from NADH |
| NDUFV3 | Accessory subunit | Assembly and stability of complex I |
| NDUFA1 | Accessory subunit | X-linked complex I deficiency; model for KO studies |
| NDUFA2 | Accessory subunit | Assembly and stability |
| NDUFA9 | Accessory subunit | Structural integrity of complex I |
| NDUFA10 | Accessory subunit | Complex I assembly and function |
| NDUFB8 | Accessory subunit | Marker of complex I abundance |
| NDUFB11 | Accessory subunit | X-linked complex I deficiency |
| NDUFS4 | Accessory subunit | Assembly and disease relevance |
| NDUFS7 | Core subunit | Ubiquinone binding and proton pumping |
| NDUFS8 | Core subunit | Iron-sulfur cluster containing subunit |
| NDUFAB1 | Acyl carrier protein subunit | Complex I assembly and stability |
| RTN4IP1 | Assembly factor for late stages of complex I and CoQ biosynthesis | Required for final assembly and coenzyme Q biosynthesis |
How Is mitochondrial electron transport, NADH to ubiquinone Regulated?
The process of mitochondrial electron transport, NADH to ubiquinone is regulated at multiple levels, including the availability of substrates NADH and ubiquinone, the assembly state of complex I, and the expression of its subunits. The ubiquinone pool acts as a mobile electron carrier whose redox state influences electron flux through the respiratory chain. Assembly of complex I is regulated by dedicated assembly factors, and RTN4IP1 is required for the final stages of complex I assembly and for coenzyme Q biosynthesis, thereby influencing both the enzyme and its substrate. Inhibitors and artificial electron acceptors can modulate the reaction and are used to study its regulation and potential pharmacological control. In addition, thyroid thermogenesis has been historically linked to mitochondrial electron transport and energy expenditure, reflecting systemic regulation of oxidative phosphorylation.
mitochondrial electron transport, NADH to ubiquinone and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NDUFS1 | Complex I deficiency and mitochondrial disease | Knockout or point-mutation cell models |
| NDUFS4 | Complex I deficiency | Knockout and rescue models |
| NDUFA1 | X-linked complex I deficiency | Knockout in neuronal cells |
| RTN4IP1 | Complex I assembly defect and CoQ biosynthesis impairment | Knockout and knock-in models |
| NDUFV1 | Complex I dysfunction | Point-mutation knock-in models |
Mitochondrial complex I deficiency and mitochondrial disease
Defects in mitochondrial complex I, the enzyme that catalyzes GO:0006120, are a common cause of mitochondrial disease, and mutations in both core and accessory subunits can impair NADH to ubiquinone electron transfer. Assembly defects, including those involving RTN4IP1, lead to reduced complex I levels and can also affect coenzyme Q biosynthesis, further compromising the process. Such defects reduce oxidative phosphorylation capacity and can present with a broad spectrum of clinical phenotypes.
Cancer metabolism and tumour growth
Ubiquinol oxidation downstream of complex I is necessary for tumour growth, linking GO:0006120 to cancer metabolism. This finding indicates that the NADH to ubiquinone electron transfer step supports biosynthetic and bioenergetic demands of proliferating tumour cells. Therefore, components of this process are being explored as potential targets in cancer research.
Pharmacological targeting of complex I
Complex I is a target for inhibitors and potential medicines, and its interaction with artificial electron acceptors has been studied to understand the mechanism of NADH to ubiquinone electron transfer. Such studies provide a basis for developing drugs that modulate mitochondrial electron transport for therapeutic purposes. The process is therefore relevant to pharmacology and drug discovery.
From mitochondrial electron transport, NADH to ubiquinone-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a complex I subunit impair NADH to ubiquinone electron transfer? | Knockout cell model |
| Does a specific patient mutation affect complex I assembly or activity? | Point-mutation knock-in model |
| Can a tagged subunit be used to monitor complex I assembly? | Tagged knock-in model |
| Does overexpression of an assembly factor rescue complex I levels? | Overexpression model |
| Which genes are essential for complex I function? | CRISPR library screening |
| Can a candidate gene be causally linked to the process? | Knockout plus rescue experiments |
How to Study the mitochondrial electron transport, NADH to ubiquinone Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Spectrophotometric assay with artificial electron acceptors | Complex I NADH:ubiquinone oxidoreductase activity | Testing effects of mutations or inhibitors |
| Blue native PAGE and immunoblotting | Complex I assembly and abundance | Evaluating assembly defects |
| Respirometry | Oxygen consumption and respiratory chain flux | Assessing oxidative phosphorylation capacity |
| RNA sequencing | Expression of complex I subunits and assembly factors | Identifying regulatory changes |
| Proteomics | Protein levels of respiratory chain components | Validating assembly and stoichiometry |
| CRISPR library screening | Essential genes for complex I function | Discovering novel regulators |
| Fluorescence microscopy | Mitochondrial morphology and membrane potential | Linking function to cellular phenotype |
Measuring electron transfer activity
The NADH to ubiquinone electron transfer activity of complex I can be measured using artificial electron acceptors and inhibitors in spectrophotometric assays. Such assays allow researchers to quantify the catalytic activity of complex I and to test the effects of mutations or drugs. They are widely used to characterize cell models with edited genes.
Assessing complex I assembly and abundance
Complex I assembly can be assessed by blue native polyacrylamide gel electrophoresis and immunoblotting with antibodies against subunits such as NDUFB8. These methods reveal whether mutations or assembly factor defects, such as those involving RTN4IP1, impair the formation of the holoenzyme. They are essential for linking genotype to the functional process defined by GO:0006120.
Respirometry and metabolic flux analysis
Respirometry using oxygen consumption measurements can evaluate the overall flux through the respiratory chain and the contribution of complex I. This approach helps determine whether changes in NADH to ubiquinone electron transfer affect oxidative phosphorylation and cellular metabolism. It is often combined with genetic editing to test causality.
Transcriptomics and proteomics
RNA sequencing and proteomics can quantify the expression of complex I subunits and assembly factors, providing insight into how the process is regulated. These methods can identify compensatory changes in response to genetic perturbations. They are useful for hypothesis generation before targeted functional studies.
How CRISPR Can Be Used to Study GO:0006120 mitochondrial electron transport, NADH to ubiquinone
Knockout
CRISPR knockout of genes encoding complex I subunits or assembly factors such as RTN4IP1 can abolish NADH to ubiquinone electron transfer and impair oxidative phosphorylation. These models are used to determine whether a candidate gene is required for the process and to study downstream metabolic consequences. Knockout cells can be rescued by re-expression to confirm specificity.
Point Mutation
CRISPR point mutation can introduce patient-derived missense variants into genes such as NDUFS1 or NDUFV1 to model complex I deficiency. These models allow researchers to dissect the effect of a single amino acid change on electron transfer and assembly. They are valuable for genotype-phenotype correlation.
Knock-in
Knock-in of tags or reporter sequences into complex I subunit genes enables monitoring of protein localization and assembly in live cells. This approach can reveal how mutations affect the incorporation of subunits into the holoenzyme. It is also useful for studying the late assembly stages involving RTN4IP1.
Overexpression
Overexpression of complex I subunits or assembly factors can test whether increased levels enhance or rescue NADH to ubiquinone electron transfer. Such models help identify rate-limiting components of the process. They are also used to study the effects of excess coenzyme Q biosynthesis factors.
How EDITGENE Supports mitochondrial electron transport, NADH to ubiquinone Research
Researchers studying mitochondrial electron transport, NADH to ubiquinone-related genes often need to determine whether a candidate gene is causally involved in complex I function, assembly, or regulation. EDITGENE provides a comprehensive suite of CRISPR-based cell model services to support such investigations, from knockout to knock-in and library screening.
Contact EDITGENE today to design your custom CRISPR model for mitochondrial electron transport, NADH to ubiquinone research.
Frequently Asked Questions About mitochondrial electron transport, NADH to ubiquinone
What is GO:0006120?
GO:0006120 is the biological process of mitochondrial electron transport, NADH to ubiquinone, in which electrons are transferred from NADH to ubiquinone during oxidative phosphorylation, catalyzed by complex I.
What genes are involved in mitochondrial electron transport, NADH to ubiquinone?
Genes encoding complex I subunits such as NDUFS1, NDUFS2, NDUFS3, NDUFV1, NDUFV2, NDUFA1, NDUFA2, NDUFA9, NDUFA10, NDUFB8, NDUFB11, NDUFS4, NDUFS7, NDUFS8, and NDUFAB1, as well as assembly factors like RTN4IP1, are involved.
Which enzyme catalyzes the transfer of electrons from NADH to ubiquinone?
Mitochondrial complex I, also known as NADH:ubiquinone oxidoreductase, catalyzes this reaction.
Why is complex I important for cellular energy production?
Complex I couples NADH oxidation and ubiquinone reduction to proton translocation, generating the proton motive force used for ATP synthesis.
What diseases are associated with defects in NADH to ubiquinone electron transfer?
Defects in complex I are associated with mitochondrial diseases, and ubiquinol oxidation downstream of complex I is necessary for tumour growth.
How can I study mitochondrial electron transport, NADH to ubiquinone in the lab?
Common methods include spectrophotometric assays with artificial electron acceptors, blue native PAGE, respirometry, and CRISPR-based genetic models.
What is the role of RTN4IP1 in complex I function?
RTN4IP1 is required for the final stages of mitochondrial complex I assembly and for coenzyme Q biosynthesis.
Can complex I be targeted by drugs?
Yes, complex I is a target for inhibitors and potential medicines, and its interaction with artificial electron acceptors has been studied.
What is the relationship between complex I and coenzyme Q?
Complex I reduces ubiquinone (coenzyme Q) to ubiquinol, and coenzyme Q biosynthesis is linked to complex I assembly via factors such as RTN4IP1.
How does complex I contribute to reactive oxygen species production?
When electron transfer is impaired, complex I can become a source of reactive oxygen species, which contributes to cellular stress.
Conclusion
GO:0006120, mitochondrial electron transport, NADH to ubiquinone, is a fundamental biological process that defines the entry of electrons from NADH into the respiratory chain via complex I. Its correct function is essential for oxidative phosphorylation, and its dysfunction is linked to mitochondrial disease and cancer metabolism. Understanding the molecular mechanism, assembly, and regulation of this process provides a basis for therapeutic development and for interpreting genetic variants. Researchers can leverage CRISPR-based cell models to dissect the roles of individual genes in this pathway.
References
- 1. Hirst J. 2013. Mitochondrial complex I.. Annu Rev Biochem 82:551-75 PMID: 23527692
- 3. Oláhová M et al.. 2025. RTN4IP1 is required for the final stages of mitochondrial complex I assembly and CoQ biosynthesis.. EMBO J 44(19):5482-5508 PMID: 40859035
- 4. Martínez-Reyes I et al.. 2020. Mitochondrial ubiquinol oxidation is necessary for tumour growth.. Nature 585(7824):288-292 PMID: 32641834
- 5. Grivennikova VG et al.. 2024. Proton-Translocating NADH-Ubiquinone Oxidoreductase: Interaction with Artificial Electron Acceptors, Inhibitors, and Potential Medicines.. Int J Mol Sci 25(24) PMID: 39769185
- 7. Edelman IS. 1974. Thyroid thermogenesis.. N Engl J Med 290(23):1303-8 PMID: 4363889
- 8. Gutman M. 1980. Electron flux through the mitochondrial ubiquinone.. Biochim Biophys Acta 594(1):53-84 PMID: 7006698
